Hello, Fool! | Login | Signup | My Fool
Oct 11, 2008 8:27 AM ET | Feedback | Site Changes | Help
A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.
View All Commentary (AMLN)
Recs
legal123 (< 20) Submitted: 2/15/07 5:10 PM : Start Price: $40.05 AMLN Score: 30.14
Remarkable that weekly
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK